The global Apigenin market size was valued at USD 132.3 million in 2023 and is forecast to a readjusted size of USD 168.8 million by 2030 with a CAGR of 3.5% during review period.
Apigenin is a polyphenol, and is one of the flavonoids found in many of the foods consumed by humans.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market鈥檚 growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
This report includes an overview of the development of the Apigenin industry chain, the market status of Pharma and Healthcare (0.95, 0.98), Food Additives (0.95, 0.98), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Apigenin.
Regionally, the report analyzes the Apigenin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Apigenin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Apigenin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Apigenin industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (MT), revenue generated, and market share of different by Type (e.g., 0.95, 0.98).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Apigenin market.
Regional Analysis: The report involves examining the Apigenin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Apigenin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Apigenin:
Company Analysis: Report covers individual Apigenin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Apigenin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharma and Healthcare, Food Additives).
Technology Analysis: Report covers specific technologies relevant to Apigenin. It assesses the current state, advancements, and potential future developments in Apigenin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Apigenin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Apigenin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
0.95
0.98
Others
麻豆原创 segment by Application
Pharma and Healthcare
Food Additives
Cosmetic and Skin Care
Others
Major players covered
Monteloeder
Aksuvital
Bo International
Indo Phytochem Pharmaceuticals
Shaanxi QingLan Bio-Technology
Xian Pincredit Bio-Tech
Xi an Sost Biotech
Shaanxi Pioneer Biotech
Xi'an Lyphar Biotech
Jiaherb
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Apigenin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Apigenin, with price, sales, revenue and global market share of Apigenin from 2019 to 2024.
Chapter 3, the Apigenin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Apigenin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Apigenin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Apigenin.
Chapter 14 and 15, to describe Apigenin sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Apigenin
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Apigenin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 0.95
1.3.3 0.98
1.3.4 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Apigenin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharma and Healthcare
1.4.3 Food Additives
1.4.4 Cosmetic and Skin Care
1.4.5 Others
1.5 Global Apigenin 麻豆原创 Size & Forecast
1.5.1 Global Apigenin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Apigenin Sales Quantity (2019-2030)
1.5.3 Global Apigenin Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Monteloeder
2.1.1 Monteloeder Details
2.1.2 Monteloeder Major Business
2.1.3 Monteloeder Apigenin Product and Services
2.1.4 Monteloeder Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Monteloeder Recent Developments/Updates
2.2 Aksuvital
2.2.1 Aksuvital Details
2.2.2 Aksuvital Major Business
2.2.3 Aksuvital Apigenin Product and Services
2.2.4 Aksuvital Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Aksuvital Recent Developments/Updates
2.3 Bo International
2.3.1 Bo International Details
2.3.2 Bo International Major Business
2.3.3 Bo International Apigenin Product and Services
2.3.4 Bo International Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Bo International Recent Developments/Updates
2.4 Indo Phytochem Pharmaceuticals
2.4.1 Indo Phytochem Pharmaceuticals Details
2.4.2 Indo Phytochem Pharmaceuticals Major Business
2.4.3 Indo Phytochem Pharmaceuticals Apigenin Product and Services
2.4.4 Indo Phytochem Pharmaceuticals Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Indo Phytochem Pharmaceuticals Recent Developments/Updates
2.5 Shaanxi QingLan Bio-Technology
2.5.1 Shaanxi QingLan Bio-Technology Details
2.5.2 Shaanxi QingLan Bio-Technology Major Business
2.5.3 Shaanxi QingLan Bio-Technology Apigenin Product and Services
2.5.4 Shaanxi QingLan Bio-Technology Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Shaanxi QingLan Bio-Technology Recent Developments/Updates
2.6 Xian Pincredit Bio-Tech
2.6.1 Xian Pincredit Bio-Tech Details
2.6.2 Xian Pincredit Bio-Tech Major Business
2.6.3 Xian Pincredit Bio-Tech Apigenin Product and Services
2.6.4 Xian Pincredit Bio-Tech Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Xian Pincredit Bio-Tech Recent Developments/Updates
2.7 Xi an Sost Biotech
2.7.1 Xi an Sost Biotech Details
2.7.2 Xi an Sost Biotech Major Business
2.7.3 Xi an Sost Biotech Apigenin Product and Services
2.7.4 Xi an Sost Biotech Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Xi an Sost Biotech Recent Developments/Updates
2.8 Shaanxi Pioneer Biotech
2.8.1 Shaanxi Pioneer Biotech Details
2.8.2 Shaanxi Pioneer Biotech Major Business
2.8.3 Shaanxi Pioneer Biotech Apigenin Product and Services
2.8.4 Shaanxi Pioneer Biotech Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Shaanxi Pioneer Biotech Recent Developments/Updates
2.9 Xi'an Lyphar Biotech
2.9.1 Xi'an Lyphar Biotech Details
2.9.2 Xi'an Lyphar Biotech Major Business
2.9.3 Xi'an Lyphar Biotech Apigenin Product and Services
2.9.4 Xi'an Lyphar Biotech Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Xi'an Lyphar Biotech Recent Developments/Updates
2.10 Jiaherb
2.10.1 Jiaherb Details
2.10.2 Jiaherb Major Business
2.10.3 Jiaherb Apigenin Product and Services
2.10.4 Jiaherb Apigenin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Jiaherb Recent Developments/Updates
3 Competitive Environment: Apigenin by Manufacturer
3.1 Global Apigenin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Apigenin Revenue by Manufacturer (2019-2024)
3.3 Global Apigenin Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Apigenin by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Apigenin Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Apigenin Manufacturer 麻豆原创 Share in 2023
3.5 Apigenin 麻豆原创: Overall Company Footprint Analysis
3.5.1 Apigenin 麻豆原创: Region Footprint
3.5.2 Apigenin 麻豆原创: Company Product Type Footprint
3.5.3 Apigenin 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Apigenin 麻豆原创 Size by Region
4.1.1 Global Apigenin Sales Quantity by Region (2019-2030)
4.1.2 Global Apigenin Consumption Value by Region (2019-2030)
4.1.3 Global Apigenin Average Price by Region (2019-2030)
4.2 North America Apigenin Consumption Value (2019-2030)
4.3 Europe Apigenin Consumption Value (2019-2030)
4.4 Asia-Pacific Apigenin Consumption Value (2019-2030)
4.5 South America Apigenin Consumption Value (2019-2030)
4.6 Middle East and Africa Apigenin Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Apigenin Sales Quantity by Type (2019-2030)
5.2 Global Apigenin Consumption Value by Type (2019-2030)
5.3 Global Apigenin Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Apigenin Sales Quantity by Application (2019-2030)
6.2 Global Apigenin Consumption Value by Application (2019-2030)
6.3 Global Apigenin Average Price by Application (2019-2030)
7 North America
7.1 North America Apigenin Sales Quantity by Type (2019-2030)
7.2 North America Apigenin Sales Quantity by Application (2019-2030)
7.3 North America Apigenin 麻豆原创 Size by Country
7.3.1 North America Apigenin Sales Quantity by Country (2019-2030)
7.3.2 North America Apigenin Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Apigenin Sales Quantity by Type (2019-2030)
8.2 Europe Apigenin Sales Quantity by Application (2019-2030)
8.3 Europe Apigenin 麻豆原创 Size by Country
8.3.1 Europe Apigenin Sales Quantity by Country (2019-2030)
8.3.2 Europe Apigenin Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Apigenin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Apigenin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Apigenin 麻豆原创 Size by Region
9.3.1 Asia-Pacific Apigenin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Apigenin Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Apigenin Sales Quantity by Type (2019-2030)
10.2 South America Apigenin Sales Quantity by Application (2019-2030)
10.3 South America Apigenin 麻豆原创 Size by Country
10.3.1 South America Apigenin Sales Quantity by Country (2019-2030)
10.3.2 South America Apigenin Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Apigenin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Apigenin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Apigenin 麻豆原创 Size by Country
11.3.1 Middle East & Africa Apigenin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Apigenin Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Apigenin 麻豆原创 Drivers
12.2 Apigenin 麻豆原创 Restraints
12.3 Apigenin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Apigenin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Apigenin
13.3 Apigenin Production Process
13.4 Apigenin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Apigenin Typical Distributors
14.3 Apigenin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Monteloeder
Aksuvital
Bo International
Indo Phytochem Pharmaceuticals
Shaanxi QingLan Bio-Technology
Xian Pincredit Bio-Tech
Xi an Sost Biotech
Shaanxi Pioneer Biotech
Xi'an Lyphar Biotech
Jiaherb
听
听
*If Applicable.
